The time-series behavior of neutrophil-to-lymphocyte ratio is useful as a predictive marker in non-small cell lung cancer.
Nivolumab improves the survival of advanced non-small cell lung cancer (NSCLC), but a significant number of patients still fail to benefit from this treatment. In this study, we evaluated the efficacy of the time-series behavior of neutrophil-to-lymphocyte ratio (NLR) in a complete blood count from...
Main Authors: | Tatsunori Kiriu, Masatsugu Yamamoto, Tatsuya Nagano, Daisuke Hazama, Reina Sekiya, Masahiro Katsurada, Daisuke Tamura, Motoko Tachihara, Kazuyuki Kobayashi, Yoshihiro Nishimura |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5814002?pdf=render |
Similar Items
-
Pseudo-Progression and the Neutrophil-to-Lymphocyte Ratio in Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors: A Case–Control Study
by: Kiriu T, et al.
Published: (2019-12-01) -
Crucial Role of Extracellular Vesicles in Bronchial Asthma
by: Tatsuya Nagano, et al.
Published: (2019-05-01) -
A novel automatic cough frequency monitoring system combining a triaxial accelerometer and a stretchable strain sensor
by: Takehiro Otoshi, et al.
Published: (2021-05-01) -
Pulmonary large cell neuroendocrine carcinoma with adrenal oligorecurrence successfully treated by adrenalectomy
by: Hiroki Sato, et al.
Published: (2020-08-01) -
High expression level of serpin peptidase inhibitor clade E member 2 is associated with poor prognosis in lung adenocarcinoma
by: Ryota Dokuni, et al.
Published: (2020-12-01)